IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
39 hedge funds and large institutions have $33.3M invested in Insight Molecular Diagnostics Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
39
Holders Change
-5
Holders Change %
-11.36%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
12
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BC
1
Broadwood Capital
New York
|
$27.2M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$1.01M |
3 |
3
Morgan Stanley
New York
|
$75K |
4 |
4
Northern Trust
Chicago,
Illinois
|
$331K |
5 |
TCIM
5
TIAA CREF Investment Management
New York
|
$56K |
Top Sellers
1 |
1
Goldman Sachs
New York
|
$0 |
2 |
2
BlackRock
New York
|
$1.44M |
3 |
3
Citigroup
New York
|
$0 |
4 |
FM
4
Family Management
New York
|
$155K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$4K |